Ensysce Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENSC and other ETFs, options, and stocks.About ENSC
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
CEOD. Lynn Kirkpatrick
CEOD. Lynn Kirkpatrick
Employees10
Employees10
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2003
Founded2003
Employees10
Employees10
ENSC Key Statistics
Market cap3.89M
Market cap3.89M
Price-Earnings ratio-0.10
Price-Earnings ratio-0.10
Dividend yield—
Dividend yield—
Average volume271.90K
Average volume271.90K
High today$0.47
High today$0.47
Low today$0.4059
Low today$0.4059
Open price$0.44
Open price$0.44
Volume260.86K
Volume260.86K
52 Week high$3.49
52 Week high$3.49
52 Week low$0.3144
52 Week low$0.3144
Stock Snapshot
Ensysce Biosciences(ENSC) stock is priced at $0.41, giving the company a market capitalization of 3.89M. It carries a P/E multiple of -0.10.
As of 2026-04-25, Ensysce Biosciences(ENSC) stock has fluctuated between $0.41 and $0.47. The current price stands at $0.41, placing the stock +2.0% above today's low and -11.9% off the high.
The Ensysce Biosciences(ENSC)'s current trading volume is 260.86K, compared to an average daily volume of 271.9K.
In the last year, Ensysce Biosciences(ENSC) shares hit a 52-week high of $3.49 and a 52-week low of $0.31.
In the last year, Ensysce Biosciences(ENSC) shares hit a 52-week high of $3.49 and a 52-week low of $0.31.
People also own
Based on the portfolios of people who own ENSC. This list is generated using Robinhood data, and it’s not a recommendation.